A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).

NCT04425538 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Infliximab

Sponsor

Tufts Medical Center

Collaborators

[object Object]